Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.850
+0.080 (4.52%)
Sep 17, 2026, 2:58 PM EDT - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $48.62 million as of September 17, 2026. Its market cap has decreased by -73.76% in one year.
Market Cap
48.62M
Enterprise Value
39.29M
1-Year Change
-73.76%
Ranking
Category
Stock Price
$1.85
ChartMarket Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $48.62M, a decrease of -84.43%. That is a compound annual growth rate of -43.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 48.62M | -65.05% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 58.29M |
| ImageneBio | 56.76M |
| Hyperion DeFi | 56.56M |
| Edesa Biotech | 55.87M |
| Impact BioMedical | 52.20M |
| Apollomics | 50.90M |
| Instil Bio | 50.53M |
| Immutep | 49.41M |